loadpatents
Patent applications and USPTO patent grants for Lee; Kyungae.The latest application filed is for "small molecule inhibitors of ebola and lassa fever viruses and methods of use".
Patent | Date |
---|---|
Small Molecule Inhibitors Of Ebola And Lassa Fever Viruses And Methods Of Use App 20210163454 - Cunningham; James ;   et al. | 2021-06-03 |
Method of treating Ebola Grant 9,676,763 - Cunningham , et al. June 13, 2 | 2017-06-13 |
Small molecule inhibitors of ebola and lassa fever viruses Grant 9,452,992 - Cunningham , et al. September 27, 2 | 2016-09-27 |
Type III secretion inhibitors, analogs and uses thereof Grant 9,340,505 - Goguen , et al. May 17, 2 | 2016-05-17 |
Small Molecule Inhibitors of Ebola and Lassa Fever Viruses and Methods of Use App 20160024066 - Cunningham; James ;   et al. | 2016-01-28 |
Small molecule inhibitors of ebola and lassa fever viruses and methods of use Grant 9,193,705 - Cunningham , et al. November 24, 2 | 2015-11-24 |
Small Molecule Inhibitors of Ebola and Lassa Fever Viruses App 20140329834 - Cunningham; James ;   et al. | 2014-11-06 |
Type Iii Secretion Inhibitors, Analogs And Uses Thereof App 20140323483 - Goguen; Jon ;   et al. | 2014-10-30 |
Type III secretion inhibitors, analogs and uses thereof Grant 8,716,283 - Goguen , et al. May 6, 2 | 2014-05-06 |
Methods and compounds for antimicrobial intervention Grant 8,598,342 - Kahne , et al. December 3, 2 | 2013-12-03 |
Small Molecule Inhibitors Of Ebola And Lassa Fever Viruses And Methods Of Use App 20130231332 - Cunningham; James ;   et al. | 2013-09-05 |
3-aryl-5,6-disubstituted pyridazines Grant 8,338,591 - Yoon , et al. December 25, 2 | 2012-12-25 |
Methods And Compounds For Antimicrobial Intervention App 20120046282 - Kahne; Suzanne Walker ;   et al. | 2012-02-23 |
3-substituted-6-aryl Pyridines App 20110281837 - Hutchinson; Alan J. ;   et al. | 2011-11-17 |
3-aryl-5,6-disubstituted pyridazines App 20110160187 - Yoon; Taeyoung ;   et al. | 2011-06-30 |
1-aryl-4-substituted isoquinolines Grant 7,915,288 - Lee , et al. March 29, 2 | 2011-03-29 |
Type Iii Secretion Inhibitors, Analogs And Uses Thereof App 20110034463 - Goguen; Jon ;   et al. | 2011-02-10 |
3-substituted-6-aryl pyridines Grant 7,863,454 - Hutchison , et al. January 4, 2 | 2011-01-04 |
Benzimidazole and Pyridylimidazole Derivatives App 20100267698 - Li; Guiying ;   et al. | 2010-10-21 |
Benzimidazole and pyridylimidazole derivatives Grant 7,642,267 - Li , et al. January 5, 2 | 2010-01-05 |
3-Substituted-6-Aryl Pyridines App 20090176980 - Hutchison; Alan J. ;   et al. | 2009-07-09 |
Benzimidazole and Pyridylimidazole Derivatives App 20080227793 - Li; Guiying ;   et al. | 2008-09-18 |
Monoclonal antibody specific for PPAR gamma, hydridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same Grant 7,387,895 - Yoon , et al. June 17, 2 | 2008-06-17 |
3-substituted-6-aryl pyridines Grant 7,342,115 - Hutchison , et al. March 11, 2 | 2008-03-11 |
Benzimidazole and pyridylimidazole derivatives Grant 7,300,945 - Li , et al. November 27, 2 | 2007-11-27 |
1-aryl-4-substituted isoquinolines App 20070249665 - Lee; Kyungae | 2007-10-25 |
Substituted 1-Benzyl-4-Substituted Piperazine Analogues App 20070249616 - Hutchison; Alan J. ;   et al. | 2007-10-25 |
Substituted 1-benzyl-4-substituted piperazine analogues Grant 7,253,168 - Hutchison , et al. August 7, 2 | 2007-08-07 |
Substituted 1-benzyl-4-substituted piperazine analogues App 20060142301 - Hutchison; Alan J. ;   et al. | 2006-06-29 |
Monoclonal antibody specific for ppar gamma, hybridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same App 20060140938 - Yoon; Doyoung ;   et al. | 2006-06-29 |
Benzimidazole and pyridylimidazole derivatives App 20060025425 - Li; Guiying ;   et al. | 2006-02-02 |
Aryl-substituted piperazine derivatives App 20060009456 - Hutchinson; Alan J. ;   et al. | 2006-01-12 |
Heterocyclic compounds as ligands of the GABAA receptor Grant 6,949,562 - Yohannes , et al. September 27, 2 | 2005-09-27 |
Benzimidazole and pyridylimidazole derivatives Grant 6,916,819 - Li , et al. July 12, 2 | 2005-07-12 |
Substituted tetrahydroisoquinolines as C5a receptor modulators Grant 6,916,830 - Lee , et al. July 12, 2 | 2005-07-12 |
Substituted tetrahydroisoquinolines as C5a receptor modulators App 20040204446 - Lee, Kyungae ;   et al. | 2004-10-14 |
Substituted tetrahydroisoquinolines as C5a receptor modulators Grant 6,777,422 - Lee , et al. August 17, 2 | 2004-08-17 |
3-substituted-6-aryl pyridines App 20040158067 - Hutchison, Alan J. ;   et al. | 2004-08-12 |
Heterocyclic compounds as ligands of the GABAA receptor App 20040110778 - Yohannes, Daniel ;   et al. | 2004-06-10 |
Substituted tetrahydroisoquinolines as C5a receptor modulators App 20040006069 - Lee, Kyungae ;   et al. | 2004-01-08 |
Heterocyclic compounds as ligands of the GABAA receptor Grant 6,653,471 - Yohannes , et al. November 25, 2 | 2003-11-25 |
Heterocyclic compounds as ligands of the GABAA receptor App 20030105081 - Yohannes, Daniel ;   et al. | 2003-06-05 |
Benzimidazole and pyridylimidazole derivatives App 20030069257 - Li, Guiying ;   et al. | 2003-04-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.